Sanuwave Health Posts Modest Q1 2026 Growth Amid Reimbursement Headwinds
Sanuwave Health reports Q1 2026 revenues of $9.6–$9.7M, up 3-4% YoY, citing reimbursement headwinds. CEO highlights strong Ultramist interest at SAWC conference.
SNWVregenerative medicinewound care